American Society of Clinical Oncology

SHERPA: White

People

  1. Panageas
    Panageas
  2. Scheinberg
    Scheinberg
  3. Rusch
    Rusch
  4. Zelenetz
    Zelenetz
  5. Adusumilli
    Adusumilli
  6. Dao
    Dao
  7. De Angelis
    De Angelis
  8. Fleisher
    Fleisher
  9. Ginsberg
    Ginsberg
  10. Kris
    Kris

Groups

  1. Biostatistics Service (8)
  2. Center for Hematologic Malignancies (8)
  3. Epidemiology and Biostatistics (8)
  4. Population Sciences Research Program (8)
  5. Department of Medicine (7)
  6. GSK Faculty (7)
  7. Hematologic Malignancies, Division of (7)
  8. Tow Center for Developmental Oncology (TCDO) (7)
  9. Hematologic Malignancies Research (6)
  10. Adult Leukemia (5)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Katherine Panageas"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Biostatistics Service (8)
  2. Center for Hematologic Malignancies (8)
  3. Epidemiology and Biostatistics (8)
  4. Population Sciences Research Program (8)
  5. Department of Medicine (7)
  6. GSK Faculty (7)

More Groups

People
  1. Katherine Panageas (8)
  2. David Scheinberg (5)
  3. Peter Maslak (4)
  4. Joseph Jurcic (3)
  5. Mark Weiss (3)
  6. Nicole Lamanna (3)

More People

Years
  1. 2020 (1)
  2. 2016 (1)
  3. 2012 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. JCO Clinical Cancer Informatics (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Linked Entity Attribute Pair (LEAP): A harmonization framework for data pooling
    Journal Article

    Thomas, S.; Lichtenberg, T.; Dang, K.; Fitzsimons, M.; Grossman, R. L.; Kundra, R.; Lavery, J. A.; Lenoue-Newton, M. L.; Panageas, K. S.; Sawyers, C.; more...
    JCO Clinical Cancer Informatics (2020)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immunomagnetic platform technology (IMPT) for the diagnosis of leptomeningeal metastasis in solid tumors (LMST)
    Meeting Abstract

    Nayak, L.; Fleisher, M.; Gonzalez-Espinoza, R.; Reiner, A. S.; Panageas, K.; Lin, O.; Liu, C.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL
    Meeting Abstract

    Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save